Posted by Michael Wonder on 19 Jul 2024
Outcome statement - June 2024 DUSC meeting
19 July 2024 - The outcome statement from the June 2024 DUSC meeting is now available.
The DUSC reviewed the utilisation of the following PBS listed medicines:
- Brentuximab vedotin - non-Hodgkin's lymphoma
- Galcanezumab and fremanezumab - migraine
- Semaglutide - type 2 diabetes mellitus
Read PBS News
Posted by:
Michael Wonder